FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049284927> ?p ?o ?g. }

• W3049284927 abstract "Background: Cancer chemotherapy has shifted from inpatient to outpatient settings. Thus, exposure of medical staff and family members to hazardous drugs is a serious concern. Methods: We enrolled 31 female Japanese patients (age: 54.7 ± 10.5) who had been diagnosed with breast cancer more than one month previously, had received one cycle of chemotherapy (treatment protocols including cyclophosphamide (CPA)), and had Performance Status of 0 or 1 (irrespective of age). The patients were asked to keep saliva for 3 days after outpatient chemotherapy. The saliva samples were mailed and analysed for CPA at Shionogi Analysis Centre Co., Ltd., Japan. Blood data were obtained from medical records. Ethical approval for this study was obtained from Ishikawa Nursing University (No. 561). Results: The patients received CPA ranging from 600 to 1200 mg/person (14.5 ± 4.5 mg/Kg). CPA in saliva was 13.6-79.0 (33.1 ± 13.2) mg/mL immediately after the chemotherapy and exponentially reduced with the passage of time (half-life of 6.62 ± 1.24 h). We estimated the CPA to be about 15-87% after dinner on the day of chemotherapy, 2.0-18.9% after breakfast and 0.08-5.09% after dinner on the 2nd day, and 0.02-0.6% after breakfast and 0.002-0.1% after dinner on the 3rd day. A significant positive correlation was observed between AST and half-life (γ = 0.36, P < 0.05). Conclusion: These findings show that it took one and a half days after outpatient chemotherapy to minimize the exposure risk to patients and family members. Maximum care is needed in contact with family members (cooking, eating, feeding children and washing toothbrushes).At the same time, it is necessary to minimize mental and physical stress to protect liver function." @default.
• W3049284927 created "2020-08-21" @default.
• W3049284927 creator A5007420095 @default.
• W3049284927 creator A5008176907 @default.
• W3049284927 creator A5009097912 @default.
• W3049284927 creator A5057568869 @default.
• W3049284927 creator A5074971835 @default.
• W3049284927 creator A5080473703 @default.
• W3049284927 creator A5081166185 @default.
• W3049284927 creator A5084058769 @default.
• W3049284927 date "2020-02-17" @default.
• W3049284927 modified "2023-09-23" @default.
• W3049284927 title "Suggestions for Protecting Breast Cancer Patients Receiving Outpatient Chemotherapy and Their Families Against the Exposure Risk from Salivary Cyclophosphamide" @default.
• W3049284927 doi "https://doi.org/10.15344/2394-4978/2020/320" @default.
• W3049284927 hasPublicationYear "2020" @default.
• W3049284927 type Work @default.
• W3049284927 sameAs 3049284927 @default.
• W3049284927 citedByCount "1" @default.
• W3049284927 countsByYear W30492849272021 @default.
• W3049284927 crossrefType "journal-article" @default.
• W3049284927 hasAuthorship W3049284927A5007420095 @default.
• W3049284927 hasAuthorship W3049284927A5008176907 @default.
• W3049284927 hasAuthorship W3049284927A5009097912 @default.
• W3049284927 hasAuthorship W3049284927A5057568869 @default.
• W3049284927 hasAuthorship W3049284927A5074971835 @default.
• W3049284927 hasAuthorship W3049284927A5080473703 @default.
• W3049284927 hasAuthorship W3049284927A5081166185 @default.
• W3049284927 hasAuthorship W3049284927A5084058769 @default.
• W3049284927 hasBestOaLocation W30492849271 @default.
• W3049284927 hasConcept C121608353 @default.
• W3049284927 hasConcept C126322002 @default.
• W3049284927 hasConcept C2776694085 @default.
• W3049284927 hasConcept C2776755627 @default.
• W3049284927 hasConcept C3020110884 @default.
• W3049284927 hasConcept C504460877 @default.
• W3049284927 hasConcept C530470458 @default.
• W3049284927 hasConcept C71924100 @default.
• W3049284927 hasConceptScore W3049284927C121608353 @default.
• W3049284927 hasConceptScore W3049284927C126322002 @default.
• W3049284927 hasConceptScore W3049284927C2776694085 @default.
• W3049284927 hasConceptScore W3049284927C2776755627 @default.
• W3049284927 hasConceptScore W3049284927C3020110884 @default.
• W3049284927 hasConceptScore W3049284927C504460877 @default.
• W3049284927 hasConceptScore W3049284927C530470458 @default.
• W3049284927 hasConceptScore W3049284927C71924100 @default.
• W3049284927 hasIssue "1" @default.
• W3049284927 hasLocation W30492849271 @default.
• W3049284927 hasOpenAccess W3049284927 @default.
• W3049284927 hasPrimaryLocation W30492849271 @default.
• W3049284927 hasRelatedWork W2004271404 @default.
• W3049284927 hasRelatedWork W2108971734 @default.
• W3049284927 hasRelatedWork W2365277249 @default.
• W3049284927 hasRelatedWork W2400818842 @default.
• W3049284927 hasRelatedWork W2410200968 @default.
• W3049284927 hasRelatedWork W2411938410 @default.
• W3049284927 hasRelatedWork W3049284927 @default.
• W3049284927 hasRelatedWork W3145551197 @default.
• W3049284927 hasRelatedWork W4214554217 @default.
• W3049284927 hasRelatedWork W4249342726 @default.
• W3049284927 hasVolume "7" @default.
• W3049284927 isParatext "false" @default.
• W3049284927 isRetracted "false" @default.
• W3049284927 magId "3049284927" @default.
• W3049284927 workType "article" @default.